Hiremath, A., Shiradkar, R., Fu, P., Mahran, A., Rastinehad, A., Tewari, A., Tirumani, S., Purysko, A., Ponsky, L., & Madabhushi, A.(2021).An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.The Lancet Digital Health,3(7),E445 - E454.
Hiremath, A., Shiradkar, R., Merisaari, H., Prasanna, P., Ettala, O., Taimen, P., Aronen, H., Boström, P., Jambor, I., & Madabhushi, A.(2021).Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.European Radiology,31(1),379-391.
Hiremath, A., Shiradkar, R., Merisaari, H., Prasanna, P., Ettala, O., Taimen, P., Aronen, H., Boström, P., Jambor, I., & Madabhushi, A.(2021).Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.European Radiology,31(1),379-391.
Hiremath, A., Shiradkar, R., Merisaari, H., Li, L., Prasanna, P., Ettala, O., Taimen, P., Aronen, H., Boström, P., Pierce, J., Tirumani, S., Rastinehad, A., Jambor, I., Purysko, A., & Madabhushi, A.(2020).PD57-05 A DEEP LEARNING NETWORK ALONG WITH PIRADS CAN DISTINGUISH CLINICALLY SIGNIFICANT AND INSIGNIFICANT PROSTATE CANCER ON BI-PARAMETRIC MRI: A MULTI-CENTER STUDY.The Journal of Urology,203
